Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer

NCT00217477 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: gemcitabine hydrochloride
DRUG: paricalcitol

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]